Total Payments
$1,340
2024 Payments
$375.84
Companies
17
Transactions
54
Medicare Patients
3,166
Medicare Billing
$346,397
Payment Breakdown by Category
Food & Beverage$1,315 (98.1%)
Education$25.18 (1.9%)
Other$0.00 (0.0%)
Payments by Nature
| Nature of Payment | Amount | Transactions | Share |
|---|---|---|---|
| Food and Beverage | $1,315 | 52 | 98.1% |
| Education | $25.18 | 2 | 1.9% |
Top Paying Companies
| Company | Total | Records | Latest Year |
|---|---|---|---|
| AstraZeneca Pharmaceuticals LP | $167.71 | 5 | $0 (2024) |
| Corcept Therapeutics | $158.03 | 4 | $0 (2024) |
| ABBVIE INC. | $154.43 | 8 | $0 (2024) |
| GlaxoSmithKline, LLC. | $151.21 | 3 | $0 (2023) |
| Kowa Pharmaceuticals America, Inc. | $132.85 | 1 | $0 (2018) |
| Novo Nordisk Inc | $103.59 | 6 | $0 (2024) |
| Janssen Pharmaceuticals, Inc | $92.96 | 1 | $0 (2017) |
| Amgen Inc. | $75.69 | 5 | $0 (2023) |
| PFIZER INC. | $73.20 | 5 | $0 (2023) |
| Shire North American Group Inc | $61.50 | 4 | $0 (2018) |
Payment History by Year
| Year | Amount | Transactions | Top Company |
|---|---|---|---|
| 2024 | $375.84 | 10 | Corcept Therapeutics ($158.03) |
| 2023 | $245.41 | 8 | GlaxoSmithKline, LLC. ($151.21) |
| 2022 | $31.83 | 2 | ABBVIE INC. ($31.83) |
| 2021 | $17.23 | 1 | AbbVie Inc. ($17.23) |
| 2020 | $23.09 | 1 | AbbVie Inc. ($23.09) |
| 2019 | $41.24 | 3 | Amgen Inc. ($14.53) |
| 2018 | $364.56 | 17 | Kowa Pharmaceuticals America, Inc. ($132.85) |
| 2017 | $240.78 | 12 | Janssen Pharmaceuticals, Inc ($92.96) |
All Payment Transactions
54 individual payment records from CMS Open Payments — Page 1 of 3
| Date | Company | Product | Nature | Form | Amount | Type |
|---|---|---|---|---|---|---|
| 11/20/2024 | Novo Nordisk Inc | Ozempic (Drug), Rybelsus | Food and Beverage | In-kind items and services | $22.45 | General |
| Category: Diabetes | ||||||
| 11/12/2024 | Corcept Therapeutics | Korlym (Drug) | Food and Beverage | In-kind items and services | $10.91 | General |
| Category: Endocrinology | ||||||
| 09/24/2024 | Novo Nordisk Inc | Ozempic (Drug), Rybelsus | Food and Beverage | In-kind items and services | $14.66 | General |
| Category: Diabetes | ||||||
| 09/24/2024 | Corcept Therapeutics | Korlym (Drug) | Education | In-kind items and services | $11.29 | General |
| Category: Endocrinology | ||||||
| 09/19/2024 | Lilly USA, LLC | MOUNJARO (Drug), ZEPBOUND | Food and Beverage | In-kind items and services | $24.26 | General |
| Category: Diabetes | ||||||
| 09/11/2024 | Novo Nordisk Inc | Rybelsus (Drug), Ozempic | Food and Beverage | In-kind items and services | $21.46 | General |
| Category: Diabetes | ||||||
| 08/20/2024 | Corcept Therapeutics | Korlym (Drug) | Food and Beverage | In-kind items and services | $121.00 | General |
| Category: Endocrinology | ||||||
| 07/31/2024 | Corcept Therapeutics | Korlym (Drug) | Food and Beverage | In-kind items and services | $14.83 | General |
| Category: Endocrinology | ||||||
| 04/10/2024 | ABBVIE INC. | QULIPTA (Drug) | Food and Beverage | In-kind items and services | $22.37 | General |
| Category: NEUROSCIENCE | ||||||
| 02/01/2024 | AstraZeneca Pharmaceuticals LP | AIRSUPRA (Drug) | Food and Beverage | In-kind items and services | $112.61 | General |
| Category: Respiratory | ||||||
| 10/31/2023 | GlaxoSmithKline, LLC. | SHINGRIX (Biological), AREXVY | Food and Beverage | In-kind items and services | $16.68 | General |
| Category: VACCINES | ||||||
| 09/25/2023 | GlaxoSmithKline, LLC. | SHINGRIX (Biological), AREXVY | Food and Beverage | In-kind items and services | $21.96 | General |
| Category: VACCINES | ||||||
| 09/06/2023 | PFIZER INC. | PAXLOVID (Drug) | Food and Beverage | In-kind items and services | $24.95 | General |
| Category: INFECTIOUS DISEASES | ||||||
| 08/16/2023 | ABBVIE INC. | UBRELVY (Drug) | Food and Beverage | In-kind items and services | $18.36 | General |
| Category: NEUROSCIENCE | ||||||
| 08/01/2023 | GlaxoSmithKline, LLC. | AREXVY (Drug) | Food and Beverage | In-kind items and services | $112.57 | General |
| Category: RESPIRATORY | ||||||
| 04/20/2023 | ABBVIE INC. | UBRELVY (Drug) | Food and Beverage | In-kind items and services | $20.59 | General |
| Category: NEUROSCIENCE | ||||||
| 03/15/2023 | Amgen Inc. | — | Education | In-kind items and services | $13.89 | General |
| 02/09/2023 | Novo Nordisk Inc | Wegovy (Drug), Saxenda | Food and Beverage | In-kind items and services | $16.41 | General |
| Category: Obesity | ||||||
| 05/11/2022 | ABBVIE INC. | UBRELVY (Drug) | Food and Beverage | In-kind items and services | $13.12 | General |
| Category: NEUROSCIENCE | ||||||
| 04/20/2022 | ABBVIE INC. | UBRELVY (Drug) | Food and Beverage | In-kind items and services | $18.71 | General |
| Category: NEUROSCIENCE | ||||||
| 08/25/2021 | AbbVie Inc. | LINZESS (Drug), CREON | Food and Beverage | In-kind items and services | $17.23 | General |
| Category: GASTROENTEROLOGY | ||||||
| 09/16/2020 | AbbVie Inc. | HUMIRA (Biological) | Food and Beverage | In-kind items and services | $23.09 | General |
| Category: IMMUNOLOGY | ||||||
| 09/04/2019 | Amgen Inc. | EVENITY (Biological), Prolia | Food and Beverage | In-kind items and services | $14.53 | General |
| Category: Bone Health | ||||||
| 08/21/2019 | AstraZeneca Pharmaceuticals LP | FARXIGA (Drug) | Food and Beverage | In-kind items and services | $13.13 | General |
| Category: Cardiovascular and Metabolism | ||||||
| 01/08/2019 | Takeda Pharmaceuticals U.S.A., Inc. | Trintellix (Drug) | Food and Beverage | In-kind items and services | $13.58 | General |
| Category: Central Nervous System (CNS) | ||||||
Medicare Billing by Year
| Year | Procedures | Beneficiaries | Services | Submitted | Medicare Paid |
|---|---|---|---|---|---|
| 2023 | 16 | 789 | 2,966 | $141,385 | $98,632 |
| 2022 | 15 | 797 | 2,930 | $133,320 | $89,665 |
| 2021 | 12 | 796 | 2,825 | $127,250 | $83,948 |
| 2020 | 16 | 784 | 2,745 | $129,365 | $74,153 |
Total Patients
3,166
Total Services
11,466
Medicare Billing
$346,397
Procedure Codes
59
All Medicare Procedures & Services
59 procedure records from CMS Medicare Utilization — Page 1 of 3
| HCPCS | Description | Setting | Year | Patients | Services | Charges | Medicare Paid | Ratio |
|---|---|---|---|---|---|---|---|---|
| J0897 | Injection, denosumab, 1 mg | Office | 2023 | 18 | 1,741 | $43,525 | $32,041 | 73.6% |
| 99213 | Established patient office or other outpatient visit, 20-29 minutes | Office | 2023 | 135 | 370 | $37,000 | $25,447 | 68.8% |
| G0439 | Annual wellness visit, includes a personalized prevention plan of service (pps), subsequent visit | Office | 2023 | 112 | 112 | $17,920 | $15,039 | 83.9% |
| 90662 | Influenza vaccine split virus, preservative free | Office | 2023 | 109 | 109 | $7,630 | $7,477 | 98.0% |
| 99212 | Established patient office or other outpatient visit, 10-19 minutes | Office | 2023 | 83 | 156 | $11,700 | $6,139 | 52.5% |
| G0008 | Administration of influenza virus vaccine | Office | 2023 | 121 | 121 | $4,840 | $3,933 | 81.3% |
| 99214 | Established patient office or other outpatient visit, 30-39 minutes | Office | 2023 | 25 | 30 | $4,200 | $2,880 | 68.6% |
| 99204 | New patient office or other outpatient visit, 45-59 minutes | Office | 2023 | 14 | 14 | $3,080 | $1,956 | 63.5% |
| 96372 | Injection of drug or substance under skin or into muscle | Office | 2023 | 28 | 101 | $4,545 | $1,071 | 23.6% |
| 20552 | Injection of trigger points, 1-2 muscles | Office | 2023 | 11 | 20 | $1,700 | $841.54 | 49.5% |
| 87426 | Detection test by immunoassay technique for severe acute respiratory syndrome coronavirus | Office | 2023 | 17 | 20 | $1,200 | $692.40 | 57.7% |
| G0009 | Administration of pneumococcal vaccine | Office | 2023 | 12 | 12 | $480.00 | $390.00 | 81.3% |
| 90686 | Influenza vaccine, quadrivalent, preservative free, 0.5 ml dosage | Office | 2023 | 12 | 12 | $720.00 | $261.18 | 36.3% |
| 81003 | Automated urinalysis test | Office | 2023 | 43 | 93 | $1,395 | $204.60 | 14.7% |
| 93005 | Routine electrocardiogram (ecg) using at least 12 leads with tracing | Office | 2023 | 30 | 36 | $1,260 | $177.60 | 14.1% |
| 82270 | Stool analysis for blood to screen for colon tumors | Office | 2023 | 19 | 19 | $190.00 | $81.51 | 42.9% |
| J0897 | Injection, denosumab, 1 mg | Office | 2022 | 14 | 1,680 | $42,000 | $28,389 | 67.6% |
| 99213 | Established patient office or other outpatient visit, 20-29 minutes | Office | 2022 | 121 | 316 | $31,600 | $21,479 | 68.0% |
| G0439 | Annual wellness visit, includes a personalized prevention plan of service (pps), subsequent visit | Office | 2022 | 99 | 99 | $15,840 | $13,805 | 87.2% |
| 99212 | Established patient office or other outpatient visit, 10-19 minutes | Office | 2022 | 111 | 242 | $18,150 | $9,992 | 55.1% |
| 90662 | Influenza vaccine split virus, preservative free | Office | 2022 | 108 | 108 | $7,560 | $7,334 | 97.0% |
| G0008 | Administration of influenza virus vaccine | Office | 2022 | 114 | 115 | $4,600 | $3,657 | 79.5% |
| 87426 | Detection test by immunoassay technique for severe acute respiratory syndrome coronavirus | Office | 2022 | 36 | 43 | $2,580 | $1,814 | 70.3% |
| 96372 | Injection of drug or substance under skin or into muscle | Office | 2022 | 24 | 119 | $5,355 | $1,288 | 24.0% |
| 20610 | Aspiration and/or injection of fluid from large joint | Office | 2022 | 11 | 15 | $1,350 | $700.00 | 51.9% |
About Dr. Eric Marcalus, MD
Dr. Eric Marcalus, MD is a Internal Medicine healthcare provider based in Edgewater, Maryland. This provider has been registered with the National Plan and Provider Enumeration System (NPPES) since 05/15/2006. The National Provider Identifier (NPI) number assigned to this provider is 1336190248.
According to the Centers for Medicare & Medicaid Services (CMS) Open Payments database, Dr. Eric Marcalus, MD has received a total of $1,340 in payments from pharmaceutical and medical device companies, with $375.84 received in 2024. These payments were reported across 54 transactions from 17 companies. The most common payment nature is "Food and Beverage" ($1,315).
As a Medicare-enrolled provider, Marcalus has provided services to 3,166 Medicare beneficiaries, totaling 11,466 services with total Medicare billing of $346,397. Data is available for 4 years (2020–2023), covering 59 distinct procedure/service records.
Ad
Practice Information
- Specialty Internal Medicine
- Location Edgewater, MD
- Active Since 05/15/2006
- Last Updated 08/06/2024
- Taxonomy Code 207R00000X
- Entity Type Individual
- Practice Solo Practitioner
- NPI Number 1336190248
Products in Payments
- Korlym (Drug) $158.03
- Livalo (Drug) $132.85
- AIRSUPRA (Drug) $112.61
- AREXVY (Drug) $112.57
- XARELTO (Drug) $92.96
- UBRELVY (Drug) $70.78
- FARXIGA (Drug) $55.10
- Trintellix (Drug) $48.21
- Prolia (Biological) $47.27
- SHINGRIX (Biological) $38.64
- Ozempic (Drug) $37.11
- LYRICA (Drug) $35.18
- MYDAYIS (Drug) $34.29
- Victoza (Drug) $28.61
- VYVANSE (Drug) $27.21
- PAXLOVID (Drug) $24.95
- MOUNJARO (Drug) $24.26
- HUMIRA (Biological) $23.09
- QULIPTA (Drug) $22.37
- Rybelsus (Drug) $21.46
Explore
Data Sources
Provider data from NPPES. Payment data from CMS Open Payments. Medicare data from CMS Medicare Provider Utilization. All data is public and updated periodically.
Internal Medicine Doctors in Edgewater
Dr. Domenico Rotoli, Do, DO
Internal Medicine — Payments: $13,912
Internal Medicine $13,912
Dr. Nadia Akhmed, M.d, M.D
Internal Medicine — Payments: $6,085
Internal Medicine $6,085
Anne Butler, M.d, M.D
Internal Medicine — Payments: $3,799
Internal Medicine $3,799
Jocelyn Abraham, Md, Mph, MD, MPH
Internal Medicine — Payments: $1,694
Internal Medicine $1,694
Mr. Andrei Terentiev, Md, MD
Internal Medicine — Payments: $746.41
Internal Medicine $746.41
Dr. Ellen Mcinerney, M. D, M. D
Internal Medicine
Internal Medicine